News
Evaxion A/S
EVAX · NASDAQ
$3.76+$0.05 (+1.35%)TodayMarket closed ·
Prev close $3.71
Latest news
- Press releaseGlobe Newswire
Evaxion announces business update and second quarter 2026 financial results
- News
12 Health Care Stocks Moving In Wednesday's After-Market Session
- Press releaseGlobe Newswire
Evaxion presents new preclinical data for EVX-04, an off-the-shelf therapeutic vaccine for acute myeloid leukemia
- News
12 Health Care Stocks Moving In Tuesday's After-Market Session
- News
Evaxion Earnings Report: Q4 Overview
- News
Insights into Evaxion Q4 Earnings
- Press releaseGlobe Newswire
Evaxion announces business update and full year 2025 financial results
- Press releaseGlobe Newswire
Evaxion plans to file 2025 annual report later today
- News
Earnings Scheduled For March 5, 2026
- News
Evaxion Biotech's Earnings: A Preview
- Press releaseGlobe Newswire
Evaxion expands AI-Immunology™ platform into autoimmune diseases
- NewsVandana Singh
Evaxion Seeks New Partner For Gonorrhea Vaccine After Merck Opts Out
- News
Evaxion Biotech Q3 EPS $0.01 Beats $(0.21) Estimate, Sales $7.492M Beat $2.500M Estimate
- Press releaseGlobe Newswire
Evaxion announces business update and third quarter 2025 financial results
- News
Earnings Scheduled For November 6, 2025
- News
What's Next: Evaxion Biotech's Earnings Preview
- Press releasePRNewswire
Natural Killer Cell Therapies Lead $254B Immunotherapy Market Transformation
- News
Market-Moving News for September 25th
- Press releaseGlobe Newswire
Evaxion out-licenses vaccine candidate EVX-B3 to MSD
- Press releasePRNewswire
Biotech Underdogs Line Up for Pivotal Shots at Game-Changing Cancer Treatments
- News
A Look at Evaxion Biotech's Upcoming Earnings Report
- News
Watching Evaxion Biotech; Zacks Small-Cap Research Gives Stock $19.75 Price Valuation
- NewsAvi Kapoor
Why Palantir Shares Are Trading Higher By Over 16%; Here Are 20 Stocks Moving Premarket
- NewsAvi Kapoor
Why Twilio Shares Are Trading Higher By Over 18%; Here Are 20 Stocks Moving Premarket
- News
Market-Moving News for December 27th
- News
Watching Evaxion Biotech; Zacks Small-Cap Research Gives Stock $7.25 Price Valuation
- NewsVandana Singh
Evaxion Biotech Partners With Merck To Expand Vaccine Development
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.